What is MKGAF stock price today?

Visit our real-time dashboard for the current MKGAF stock price and live market data.

Is MKGAF stock going up or down today?

MKGAF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.

Should I buy MKGAF stock now?

The decision to buy MKGAF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.

Is MKGAF a buy, hold, or sell right now?

Our AI-powered analysis provides buy/hold/sell recommendations for MKGAF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.

Is MKGAF stock overvalued or undervalued?

MKGAF currently trades at a P/E ratio of 25.60, which may indicate premium valuation. Our DCF calculator provides intrinsic value estimates to help determine if MKGAF is fairly priced.

What is MKGAF's P/E ratio?

MKGAF has a price-to-earnings (P/E) ratio of 25.60, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.

What is MKGAF's market cap?

MKGAF (MERCK Kommanditgesellschaft auf Aktien) has a market capitalization of $73.91 billion, making it a mid-cap stock.

What is MKGAF's price to book ratio?

Price-to-book ratio for MKGAF is available on our dashboard along with other valuation metrics.

Does MKGAF pay dividends?

Yes, MKGAF pays dividends with a current yield of 1.31%. Dividend payments provide income for investors in addition to potential stock price appreciation.

What is MKGAF's dividend yield?

MKGAF's dividend yield is 1.31%, calculated as annual dividends divided by the current stock price. This represents the annual return from dividends alone.

Is MKGAF stock a good long-term investment?

MKGAF's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.

What is MKGAF's revenue growth rate?

Revenue growth data for MKGAF is available on our dashboard with detailed financial statement analysis.

Profitability metrics for MKGAF are available on our dashboard with complete income statement analysis.

What are the risks of investing in MKGAF?

Key risks for MKGAF include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.

How does MKGAF compare to its competitors?

Compare MKGAF to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize MKGAF's performance and positioning.

What is MKGAF's stock price target for 2026?

Visit our prediction page for AI-powered price targets for MKGAF with bull, base, and bear case scenarios.

What do analysts say about MKGAF?

Wall Street analysts provide ratings (buy/hold/sell) and price targets for MKGAF. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.

When is MKGAF's next earnings report?

MKGAF reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.

MKGAF - MERCK Kommanditgesellschaft auf Aktien

NYSE * Healthcare * Drug Manufacturers - Specialty & Generic

$0.00

+$0.00 (+0.00%)

About MERCK Kommanditgesellschaft auf Aktien

MERCK Kommanditgesellschaft auf Aktien (MKGAF) common stock

Price Chart

Loading chart...

MKGAF Key Statistics

Market Cap

$73.91B

P/E Ratio

25.60

Dividend Yield

1.31%

How MKGAF Compares to Peers

MKGAF is the smallest among peers, which may offer higher growth potential

P/E Rank

of 6

Margin Rank

N/A

of 0

Growth Rank

N/A

of 0

Size Rank

of 6

Company	Market Cap	P/E	Growth	Margin	Compare
MKGAF(This stock)	$73.91B	25.6	0%	0.0%	-
LLYEli Lilly	$991.62B	39.5	0%	0.0%	vs LLY
JNJJohnson &	$375.37B	17.4	0%	0.0%	vs JNJ
PFEPfizer Inc	$147.73B	19.8	0%	0.0%	vs PFE
MRKMerck &	$285.12B	32.5	0%	0.0%	vs MRK
ABBVAbbVie Inc	$334.34B	80.5	0%	0.0%	vs ABBV

Data Updated: July 20, 2026 at 8:40 PM EDT

Ready to invest in MKGAF?

Commission-free trading available. Affiliate links.

Upcoming Events for MKGAF

Dashboard

Enter a ticker to analyze